“…In previous studies this drug was found to inhibit receptor‐stimulated Ca 2+ entry following store depletion in various cell types such as human platelets, neutrophils and endothelial cells (Merritt et al ., 1990), lymphocytes (Mason et al ., 1993), HL‐60 cells (Koch et al ., 1994), Jurkat T cells (Sei et al ., 1995) and in several different smooth muscles (Li et al ., 1997; Wayman et al ., 1997; Takemoto et al ., 1998; Wassdal et al ., 1998; Yang, 1998; Lagaud et al ., 1999). However, SK&F 96365 is neither very potent (the IC 50 in most cases around 10 μ M ) nor selective as it can also inhibit voltage‐gated Ca 2+ channels (Merritt et al ., 1990), K + channels (Schwarz et al ., 1994), the SR Ca 2+ ATPase (Mason et al ., 1993), stimulate phosphoinositide hydrolysis and cause intracellular Ca 2+ release (Arias‐Montano et al ., 1998) and facilitate nicotinic receptor desensitization (Hong & Chang, 1994).…”